Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVA237 in Asthma Patients
NCT03137784Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of glycopyrronium in asthma, sponsored by Novartis. Started May 2017; status: completed.
02
Drugs
glycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03137784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137784.